Patents by Inventor Mie MARKHOLM

Mie MARKHOLM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN
    Publication number: 20260248884
    Abstract: The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
    Type: Application
    Filed: February 13, 2026
    Publication date: August 27, 2026
    Inventors: Maike MOSE, Nikolaj Fibiger RITTIG, Niels MØLLER, Ulla Ramer MIKKELSEN, Pernille Dorthea FREDERIKSEN, Kasper Bøgelund LAURIDSEN, Britt CHRISTENSEN, Mie MARKHOLM, Søren Bang NIELSEN, Tanja Christine JÆGER, Stine Bech SMEDEGAARD, Adam HULMAN
  • Insulinotropic and glucagonotropic effects of beta-lactoglobulin
    Patent number: 12558401
    Abstract: The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin orb) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: February 24, 2026
    Assignee: Arla Foods Amba
    Inventors: Maike Mose, Nikolaj Fibiger Rittig, Niels Møller, Ulla Ramer Mikkelsen, Pernille Dorthea Frederiksen, Kasper Bøgelund Lauridsen, Britt Christensen, Mie Markholm, Søren Bang Nielsen, Tanja Christine Jæger, Stine Bech Smedegaard, Adam Hulman
  • INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN
    Publication number: 20230000947
    Abstract: The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin orb) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
    Type: Application
    Filed: November 20, 2020
    Publication date: January 5, 2023
    Inventors: Maike MOSE, Nikolaj Fibiger RITTIG, Niels MØLLER, Ulla Ramer MIKKELSEN, Pernille Dorthea FREDERIKSEN, Kasper Bøgelund LAURIDSEN, Britt CHRISTENSEN, Mie MARKHOLM, Søren Bang NIELSEN, Tanja Christine JÆGER, Stine Bech SMEDEGAARD, Adam HULMAN